UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Superficial Vein Thrombosis and Thrombophlebitis: Status and Expert Opinion Document

Angiology, 2007-04, Vol.58 (1S), p.7S-14S

2007

Volltextzugriff (PDF)

Topical Heparin: New Observations

Angiology, 2007-04, Vol.58 (1S), p.16S-20S

2007

Volltextzugriff (PDF)

Donor‐Derived Infections in Solid Organ Transplantation

American journal of transplantation, 2013-03, Vol.13 (s4), p.22-30

2013

Volltextzugriff (PDF)

Evaluation of coffee reference genes for relative expression studies by quantitative real-time RT-PCR

Molecular breeding, 2009-05, Vol.23 (4), p.607-616

2009

Volltextzugriff (PDF)

Contrast-Enhanced Sonography in Early Kidney Graft Dysfunction

Transplantation proceedings, 2009-05, Vol.41 (4), p.1214-1215

2009

Volltextzugriff (PDF)

10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status

Annals of oncology, 2021-12, Vol.32, p.S1378

2021

Volltextzugriff (PDF)

966P Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy

Annals of oncology, 2021-09, Vol.32, p.S834-S834

2021

Volltextzugriff (PDF)

FRI-350 - The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Journal of hepatology, 2018-04, Vol.68, p.S521-S521

2018

Volltextzugriff (PDF)

Clinical and genetic predictors of HCC occuring in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

Journal of hepatology, 2018-04, Vol.68, p.S521-S522

2018

Volltextzugriff (PDF)

The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Journal of hepatology, 2018-04, Vol.68, p.S521

2018

Volltextzugriff (PDF)

FRI-351 - Clinical and genetic predictors of HCC occuring in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

Journal of hepatology, 2018-04, Vol.68, p.S521-S522

2018

Volltextzugriff (PDF)

1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer

Annals of oncology, 2020-09, Vol.31, p.S825-S826

2020

Volltextzugriff (PDF)

1318P Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy

Annals of oncology, 2020-09, Vol.31, p.S851-S851

2020

Volltextzugriff (PDF)

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

International journal of cancer, 2015-12, Vol.137 (12), p.2947-2958

2015

Volltextzugriff (PDF)

Excellent 5-years survival for HBV cirrhotic patients developing a hepatocellular carcinoma during long-term analogs treatment

Digestive and liver disease, 2018-02, Vol.50 (1), p.11-11

2018

Volltextzugriff (PDF)

Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing

Annals of oncology, 2018-10, Vol.29, p.viii674-viii674

2018

Volltextzugriff (PDF)

AB0131 Tissue Beta 2 glycoprotein I in Brain Ischemic Injury

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.941-941

2016

Volltextzugriff (PDF)

Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patients

Digestive and liver disease, 2017-02, Vol.49 (1), p.e70-e70

2017

Volltextzugriff (PDF)

MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S390-S391

2018

Volltextzugriff (PDF)

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit from Nivolumab in Advanced Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S531-S531

2018

Volltextzugriff (PDF)

Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

Digestive and liver disease, 2018-02, Vol.50 (1), p.51-51

2018

Volltextzugriff (PDF)

P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S829-S830

2019

Volltextzugriff (PDF)

P2.03-28 Whole Exome Sequencing to Discover Lung Tumor Predisposition in Women with Previous Breast Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S726-S727

2018

Volltextzugriff (PDF)

P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S730-S731

2018

Volltextzugriff (PDF)

Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease

Neuroscience, 2008-05, Vol.153 (3), p.618-633

2008

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(62)
Tagungsberichte
(1)

Sprache

Englisch
(62)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(10)
Hematology, Oncology And Palliative Medicine
(6)
Female
(5)
Animals
(4)
Biological And Medical Sciences
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Biochemistry & Molecular Biology
(3)
Gene Expression
(3)
Genetics & Heredity
(3)
Adult
(2)
Biomedical Imaging
(2)
Biotechnology
(2)
Cardiovascular System & Cardiology
(2)
Central Nervous System
(2)
Detectors
(2)
Dna
(2)
Gallium Arsenide
(2)
Male
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of Superficial Vein Thrombosis and Thrombophlebitis: Status and Expert Opinion Document

Topical Heparin: New Observations

Donor‐Derived Infections in Solid Organ Transplantation

Evaluation of coffee reference genes for relative expression studies by quantitative real-time RT-PCR

Contrast-Enhanced Sonography in Early Kidney Graft Dysfunction

10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status

966P Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy

FRI-350 - The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Clinical and genetic predictors of HCC occuring in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

FRI-351 - Clinical and genetic predictors of HCC occuring in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer

1318P Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

Excellent 5-years survival for HBV cirrhotic patients developing a hepatocellular carcinoma during long-term analogs treatment

Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing

AB0131 Tissue Beta 2 glycoprotein I in Brain Ischemic Injury

Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patients

MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit from Nivolumab in Advanced Non-Small Cell Lung Cancer

Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years

P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)

P2.03-28 Whole Exome Sequencing to Discover Lung Tumor Predisposition in Women with Previous Breast Cancer

P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab

Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease

Suchergebnisse filtern